 | • レポートコード：MRC2-11QY10450 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はTリンパ球活性化抗原CD80のグローバル市場について調査・分析したレポートです。種類別（アバタセプト、アバタセプトバイオシミラー、CUE-201、KAHR-102、その他）市場規模、用途別（代謝性疾患、自己免疫疾患、急性骨髄性白血病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別Tリンパ球活性化抗原CD80の競争状況、市場シェア ・世界のTリンパ球活性化抗原CD80市場：種類別市場規模 2015年-2020年（アバタセプト、アバタセプトバイオシミラー、CUE-201、KAHR-102、その他） ・世界のTリンパ球活性化抗原CD80市場：種類別市場規模予測 2021年-2026年（アバタセプト、アバタセプトバイオシミラー、CUE-201、KAHR-102、その他） ・世界のTリンパ球活性化抗原CD80市場：用途別市場規模 2015年-2020年（代謝性疾患、自己免疫疾患、急性骨髄性白血病、その他） ・世界のTリンパ球活性化抗原CD80市場：用途別市場規模予測 2021年-2026年（代謝性疾患、自己免疫疾患、急性骨髄性白血病、その他） ・北米のTリンパ球活性化抗原CD80市場分析：米国、カナダ ・ヨーロッパのTリンパ球活性化抗原CD80市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのTリンパ球活性化抗原CD80市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のTリンパ球活性化抗原CD80市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのTリンパ球活性化抗原CD80市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：3SBio Inc、BioAtla LLC、Bristol-Myers Squibb Co、KAHR medical Ltd、MedImmune LLC、Mologen AG ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global T Lymphocyte Activation Antigen CD80 Market
The global T Lymphocyte Activation Antigen CD80 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global T Lymphocyte Activation Antigen CD80 Scope and Market Size
T Lymphocyte Activation Antigen CD80 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global T Lymphocyte Activation Antigen CD80 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the T Lymphocyte Activation Antigen CD80 market is segmented into
Abatacept
Abatacept Biosimilar
CUE-201
KAHR-102
Others
Segment by Application, the T Lymphocyte Activation Antigen CD80 market is segmented into
Metabolic Disorders
Autoimmune Disorders
Acute Myelocytic Leukemia
Others
Regional and Country-level Analysis
The T Lymphocyte Activation Antigen CD80 market is analysed and market size information is provided by regions (countries).
The key regions covered in the T Lymphocyte Activation Antigen CD80 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and T Lymphocyte Activation Antigen CD80 Market Share Analysis
T Lymphocyte Activation Antigen CD80 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in T Lymphocyte Activation Antigen CD80 business, the date to enter into the T Lymphocyte Activation Antigen CD80 market, T Lymphocyte Activation Antigen CD80 product introduction, recent developments, etc.
The major vendors covered:
3SBio Inc
BioAtla LLC
Bristol-Myers Squibb Co
KAHR medical Ltd
MedImmune LLC
Mologen AG
…
1 Study Coverage
1.1 T Lymphocyte Activation Antigen CD80 Product Introduction
1.2 Market Segments
1.3 Key T Lymphocyte Activation Antigen CD80 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global T Lymphocyte Activation Antigen CD80 Market Size Growth Rate by Type
1.4.2 Abatacept
1.4.3 Abatacept Biosimilar
1.4.4 CUE-201
1.4.5 KAHR-102
1.4.6 Others
1.5 Market by Application
1.5.1 Global T Lymphocyte Activation Antigen CD80 Market Size Growth Rate by Application
1.5.2 Metabolic Disorders
1.5.3 Autoimmune Disorders
1.5.4 Acute Myelocytic Leukemia
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global T Lymphocyte Activation Antigen CD80 Market Size, Estimates and Forecasts
2.1.1 Global T Lymphocyte Activation Antigen CD80 Revenue 2015-2026
2.1.2 Global T Lymphocyte Activation Antigen CD80 Sales 2015-2026
2.2 Global T Lymphocyte Activation Antigen CD80, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global T Lymphocyte Activation Antigen CD80 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global T Lymphocyte Activation Antigen CD80 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global T Lymphocyte Activation Antigen CD80 Competitor Landscape by Players
3.1 T Lymphocyte Activation Antigen CD80 Sales by Manufacturers
3.1.1 T Lymphocyte Activation Antigen CD80 Sales by Manufacturers (2015-2020)
3.1.2 T Lymphocyte Activation Antigen CD80 Sales Market Share by Manufacturers (2015-2020)
3.2 T Lymphocyte Activation Antigen CD80 Revenue by Manufacturers
3.2.1 T Lymphocyte Activation Antigen CD80 Revenue by Manufacturers (2015-2020)
3.2.2 T Lymphocyte Activation Antigen CD80 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global T Lymphocyte Activation Antigen CD80 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by T Lymphocyte Activation Antigen CD80 Revenue in 2019
3.2.5 Global T Lymphocyte Activation Antigen CD80 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 T Lymphocyte Activation Antigen CD80 Price by Manufacturers
3.4 T Lymphocyte Activation Antigen CD80 Manufacturing Base Distribution, Product Types
3.4.1 T Lymphocyte Activation Antigen CD80 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers T Lymphocyte Activation Antigen CD80 Product Type
3.4.3 Date of International Manufacturers Enter into T Lymphocyte Activation Antigen CD80 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global T Lymphocyte Activation Antigen CD80 Market Size by Type (2015-2020)
4.1.1 Global T Lymphocyte Activation Antigen CD80 Sales by Type (2015-2020)
4.1.2 Global T Lymphocyte Activation Antigen CD80 Revenue by Type (2015-2020)
4.1.3 T Lymphocyte Activation Antigen CD80 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global T Lymphocyte Activation Antigen CD80 Market Size Forecast by Type (2021-2026)
4.2.1 Global T Lymphocyte Activation Antigen CD80 Sales Forecast by Type (2021-2026)
4.2.2 Global T Lymphocyte Activation Antigen CD80 Revenue Forecast by Type (2021-2026)
4.2.3 T Lymphocyte Activation Antigen CD80 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global T Lymphocyte Activation Antigen CD80 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global T Lymphocyte Activation Antigen CD80 Market Size by Application (2015-2020)
5.1.1 Global T Lymphocyte Activation Antigen CD80 Sales by Application (2015-2020)
5.1.2 Global T Lymphocyte Activation Antigen CD80 Revenue by Application (2015-2020)
5.1.3 T Lymphocyte Activation Antigen CD80 Price by Application (2015-2020)
5.2 T Lymphocyte Activation Antigen CD80 Market Size Forecast by Application (2021-2026)
5.2.1 Global T Lymphocyte Activation Antigen CD80 Sales Forecast by Application (2021-2026)
5.2.2 Global T Lymphocyte Activation Antigen CD80 Revenue Forecast by Application (2021-2026)
5.2.3 Global T Lymphocyte Activation Antigen CD80 Price Forecast by Application (2021-2026)
6 North America
6.1 North America T Lymphocyte Activation Antigen CD80 by Country
6.1.1 North America T Lymphocyte Activation Antigen CD80 Sales by Country
6.1.2 North America T Lymphocyte Activation Antigen CD80 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America T Lymphocyte Activation Antigen CD80 Market Facts & Figures by Type
6.3 North America T Lymphocyte Activation Antigen CD80 Market Facts & Figures by Application
7 Europe
7.1 Europe T Lymphocyte Activation Antigen CD80 by Country
7.1.1 Europe T Lymphocyte Activation Antigen CD80 Sales by Country
7.1.2 Europe T Lymphocyte Activation Antigen CD80 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe T Lymphocyte Activation Antigen CD80 Market Facts & Figures by Type
7.3 Europe T Lymphocyte Activation Antigen CD80 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific T Lymphocyte Activation Antigen CD80 by Region
8.1.1 Asia Pacific T Lymphocyte Activation Antigen CD80 Sales by Region
8.1.2 Asia Pacific T Lymphocyte Activation Antigen CD80 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific T Lymphocyte Activation Antigen CD80 Market Facts & Figures by Type
8.3 Asia Pacific T Lymphocyte Activation Antigen CD80 Market Facts & Figures by Application
9 Latin America
9.1 Latin America T Lymphocyte Activation Antigen CD80 by Country
9.1.1 Latin America T Lymphocyte Activation Antigen CD80 Sales by Country
9.1.2 Latin America T Lymphocyte Activation Antigen CD80 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America T Lymphocyte Activation Antigen CD80 Market Facts & Figures by Type
9.3 Central & South America T Lymphocyte Activation Antigen CD80 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa T Lymphocyte Activation Antigen CD80 by Country
10.1.1 Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales by Country
10.1.2 Middle East and Africa T Lymphocyte Activation Antigen CD80 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Facts & Figures by Type
10.3 Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Facts & Figures by Application
11 Company Profiles
11.1 3SBio Inc
11.1.1 3SBio Inc Corporation Information
11.1.2 3SBio Inc Description and Business Overview
11.1.3 3SBio Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3SBio Inc T Lymphocyte Activation Antigen CD80 Products Offered
11.1.5 3SBio Inc Related Developments
11.2 BioAtla LLC
11.2.1 BioAtla LLC Corporation Information
11.2.2 BioAtla LLC Description and Business Overview
11.2.3 BioAtla LLC Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BioAtla LLC T Lymphocyte Activation Antigen CD80 Products Offered
11.2.5 BioAtla LLC Related Developments
11.3 Bristol-Myers Squibb Co
11.3.1 Bristol-Myers Squibb Co Corporation Information
11.3.2 Bristol-Myers Squibb Co Description and Business Overview
11.3.3 Bristol-Myers Squibb Co Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bristol-Myers Squibb Co T Lymphocyte Activation Antigen CD80 Products Offered
11.3.5 Bristol-Myers Squibb Co Related Developments
11.4 KAHR medical Ltd
11.4.1 KAHR medical Ltd Corporation Information
11.4.2 KAHR medical Ltd Description and Business Overview
11.4.3 KAHR medical Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 KAHR medical Ltd T Lymphocyte Activation Antigen CD80 Products Offered
11.4.5 KAHR medical Ltd Related Developments
11.5 MedImmune LLC
11.5.1 MedImmune LLC Corporation Information
11.5.2 MedImmune LLC Description and Business Overview
11.5.3 MedImmune LLC Sales, Revenue and Gross Margin (2015-2020)
11.5.4 MedImmune LLC T Lymphocyte Activation Antigen CD80 Products Offered
11.5.5 MedImmune LLC Related Developments
11.6 Mologen AG
11.6.1 Mologen AG Corporation Information
11.6.2 Mologen AG Description and Business Overview
11.6.3 Mologen AG Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Mologen AG T Lymphocyte Activation Antigen CD80 Products Offered
11.6.5 Mologen AG Related Developments
11.1 3SBio Inc
11.1.1 3SBio Inc Corporation Information
11.1.2 3SBio Inc Description and Business Overview
11.1.3 3SBio Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3SBio Inc T Lymphocyte Activation Antigen CD80 Products Offered
11.1.5 3SBio Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 T Lymphocyte Activation Antigen CD80 Market Estimates and Projections by Region
12.1.1 Global T Lymphocyte Activation Antigen CD80 Sales Forecast by Regions 2021-2026
12.1.2 Global T Lymphocyte Activation Antigen CD80 Revenue Forecast by Regions 2021-2026
12.2 North America T Lymphocyte Activation Antigen CD80 Market Size Forecast (2021-2026)
12.2.1 North America: T Lymphocyte Activation Antigen CD80 Sales Forecast (2021-2026)
12.2.2 North America: T Lymphocyte Activation Antigen CD80 Revenue Forecast (2021-2026)
12.2.3 North America: T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2021-2026)
12.3 Europe T Lymphocyte Activation Antigen CD80 Market Size Forecast (2021-2026)
12.3.1 Europe: T Lymphocyte Activation Antigen CD80 Sales Forecast (2021-2026)
12.3.2 Europe: T Lymphocyte Activation Antigen CD80 Revenue Forecast (2021-2026)
12.3.3 Europe: T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific T Lymphocyte Activation Antigen CD80 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: T Lymphocyte Activation Antigen CD80 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: T Lymphocyte Activation Antigen CD80 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: T Lymphocyte Activation Antigen CD80 Market Size Forecast by Region (2021-2026)
12.5 Latin America T Lymphocyte Activation Antigen CD80 Market Size Forecast (2021-2026)
12.5.1 Latin America: T Lymphocyte Activation Antigen CD80 Sales Forecast (2021-2026)
12.5.2 Latin America: T Lymphocyte Activation Antigen CD80 Revenue Forecast (2021-2026)
12.5.3 Latin America: T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: T Lymphocyte Activation Antigen CD80 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: T Lymphocyte Activation Antigen CD80 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: T Lymphocyte Activation Antigen CD80 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key T Lymphocyte Activation Antigen CD80 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 T Lymphocyte Activation Antigen CD80 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. T Lymphocyte Activation Antigen CD80 Market Segments
Table 2. Ranking of Global Top T Lymphocyte Activation Antigen CD80 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global T Lymphocyte Activation Antigen CD80 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Abatacept
Table 5. Major Manufacturers of Abatacept Biosimilar
Table 6. Major Manufacturers of CUE-201
Table 7. Major Manufacturers of KAHR-102
Table 8. Major Manufacturers of Others
Table 9. Global T Lymphocyte Activation Antigen CD80 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global T Lymphocyte Activation Antigen CD80 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global T Lymphocyte Activation Antigen CD80 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global T Lymphocyte Activation Antigen CD80 Sales Market Share by Regions (2015-2020)
Table 13. Global T Lymphocyte Activation Antigen CD80 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global T Lymphocyte Activation Antigen CD80 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global T Lymphocyte Activation Antigen CD80 Sales Share by Manufacturers (2015-2020)
Table 16. Global T Lymphocyte Activation Antigen CD80 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global T Lymphocyte Activation Antigen CD80 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T Lymphocyte Activation Antigen CD80 as of 2019)
Table 18. T Lymphocyte Activation Antigen CD80 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. T Lymphocyte Activation Antigen CD80 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers T Lymphocyte Activation Antigen CD80 Price (2015-2020) (USD/Pcs)
Table 21. T Lymphocyte Activation Antigen CD80 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers T Lymphocyte Activation Antigen CD80 Product Type
Table 23. Date of International Manufacturers Enter into T Lymphocyte Activation Antigen CD80 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global T Lymphocyte Activation Antigen CD80 Sales by Type (2015-2020) (K Pcs)
Table 26. Global T Lymphocyte Activation Antigen CD80 Sales Share by Type (2015-2020)
Table 27. Global T Lymphocyte Activation Antigen CD80 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global T Lymphocyte Activation Antigen CD80 Revenue Share by Type (2015-2020)
Table 29. T Lymphocyte Activation Antigen CD80 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global T Lymphocyte Activation Antigen CD80 Sales by Application (2015-2020) (K Pcs)
Table 31. Global T Lymphocyte Activation Antigen CD80 Sales Share by Application (2015-2020)
Table 32. North America T Lymphocyte Activation Antigen CD80 Sales by Country (2015-2020) (K Pcs)
Table 33. North America T Lymphocyte Activation Antigen CD80 Sales Market Share by Country (2015-2020)
Table 34. North America T Lymphocyte Activation Antigen CD80 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America T Lymphocyte Activation Antigen CD80 Revenue Market Share by Country (2015-2020)
Table 36. North America T Lymphocyte Activation Antigen CD80 Sales by Type (2015-2020) (K Pcs)
Table 37. North America T Lymphocyte Activation Antigen CD80 Sales Market Share by Type (2015-2020)
Table 38. North America T Lymphocyte Activation Antigen CD80 Sales by Application (2015-2020) (K Pcs)
Table 39. North America T Lymphocyte Activation Antigen CD80 Sales Market Share by Application (2015-2020)
Table 40. Europe T Lymphocyte Activation Antigen CD80 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe T Lymphocyte Activation Antigen CD80 Sales Market Share by Country (2015-2020)
Table 42. Europe T Lymphocyte Activation Antigen CD80 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe T Lymphocyte Activation Antigen CD80 Revenue Market Share by Country (2015-2020)
Table 44. Europe T Lymphocyte Activation Antigen CD80 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe T Lymphocyte Activation Antigen CD80 Sales Market Share by Type (2015-2020)
Table 46. Europe T Lymphocyte Activation Antigen CD80 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe T Lymphocyte Activation Antigen CD80 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific T Lymphocyte Activation Antigen CD80 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific T Lymphocyte Activation Antigen CD80 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific T Lymphocyte Activation Antigen CD80 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific T Lymphocyte Activation Antigen CD80 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific T Lymphocyte Activation Antigen CD80 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific T Lymphocyte Activation Antigen CD80 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific T Lymphocyte Activation Antigen CD80 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific T Lymphocyte Activation Antigen CD80 Sales Market Share by Application (2015-2020)
Table 56. Latin America T Lymphocyte Activation Antigen CD80 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America T Lymphocyte Activation Antigen CD80 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa T Lymphocyte Activation Antigen CD80 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America T Lymphocyte Activation Antigen CD80 Revenue Market Share by Country (2015-2020)
Table 60. Latin America T Lymphocyte Activation Antigen CD80 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America T Lymphocyte Activation Antigen CD80 Sales Market Share by Type (2015-2020)
Table 62. Latin America T Lymphocyte Activation Antigen CD80 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America T Lymphocyte Activation Antigen CD80 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa T Lymphocyte Activation Antigen CD80 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa T Lymphocyte Activation Antigen CD80 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Market Share by Application (2015-2020)
Table 72. 3SBio Inc Corporation Information
Table 73. 3SBio Inc Description and Major Businesses
Table 74. 3SBio Inc T Lymphocyte Activation Antigen CD80 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. 3SBio Inc Product
Table 76. 3SBio Inc Recent Development
Table 77. BioAtla LLC Corporation Information
Table 78. BioAtla LLC Description and Major Businesses
Table 79. BioAtla LLC T Lymphocyte Activation Antigen CD80 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. BioAtla LLC Product
Table 81. BioAtla LLC Recent Development
Table 82. Bristol-Myers Squibb Co Corporation Information
Table 83. Bristol-Myers Squibb Co Description and Major Businesses
Table 84. Bristol-Myers Squibb Co T Lymphocyte Activation Antigen CD80 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Bristol-Myers Squibb Co Product
Table 86. Bristol-Myers Squibb Co Recent Development
Table 87. KAHR medical Ltd Corporation Information
Table 88. KAHR medical Ltd Description and Major Businesses
Table 89. KAHR medical Ltd T Lymphocyte Activation Antigen CD80 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. KAHR medical Ltd Product
Table 91. KAHR medical Ltd Recent Development
Table 92. MedImmune LLC Corporation Information
Table 93. MedImmune LLC Description and Major Businesses
Table 94. MedImmune LLC T Lymphocyte Activation Antigen CD80 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. MedImmune LLC Product
Table 96. MedImmune LLC Recent Development
Table 97. Mologen AG Corporation Information
Table 98. Mologen AG Description and Major Businesses
Table 99. Mologen AG T Lymphocyte Activation Antigen CD80 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Mologen AG Product
Table 101. Mologen AG Recent Development
Table 102. Global T Lymphocyte Activation Antigen CD80 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 103. Global T Lymphocyte Activation Antigen CD80 Sales Market Share Forecast by Regions (2021-2026)
Table 104. Global T Lymphocyte Activation Antigen CD80 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 105. Global T Lymphocyte Activation Antigen CD80 Revenue Market Share Forecast by Regions (2021-2026)
Table 106. North America: T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. North America: T Lymphocyte Activation Antigen CD80 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Europe: T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Europe: T Lymphocyte Activation Antigen CD80 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Asia Pacific: T Lymphocyte Activation Antigen CD80 Sales Forecast by Region (2021-2026) (K Pcs)
Table 111. Asia Pacific: T Lymphocyte Activation Antigen CD80 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 112. Latin America: T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. Latin America: T Lymphocyte Activation Antigen CD80 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Middle East and Africa: T Lymphocyte Activation Antigen CD80 Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. Middle East and Africa: T Lymphocyte Activation Antigen CD80 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 117. Key Challenges
Table 118. Market Risks
Table 119. Main Points Interviewed from Key T Lymphocyte Activation Antigen CD80 Players
Table 120. T Lymphocyte Activation Antigen CD80 Customers List
Table 121. T Lymphocyte Activation Antigen CD80 Distributors List
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. T Lymphocyte Activation Antigen CD80 Product Picture
Figure 2. Global T Lymphocyte Activation Antigen CD80 Sales Market Share by Type in 2020 & 2026
Figure 3. Abatacept Product Picture
Figure 4. Abatacept Biosimilar Product Picture
Figure 5. CUE-201 Product Picture
Figure 6. KAHR-102 Product Picture
Figure 7. Others Product Picture
Figure 8. Global T Lymphocyte Activation Antigen CD80 Sales Market Share by Application in 2020 & 2026
Figure 9. Metabolic Disorders
Figure 10. Autoimmune Disorders
Figure 11. Acute Myelocytic Leukemia
Figure 12. Others
Figure 13. T Lymphocyte Activation Antigen CD80 Report Years Considered
Figure 14. Global T Lymphocyte Activation Antigen CD80 Market Size 2015-2026 (US$ Million)
Figure 15. Global T Lymphocyte Activation Antigen CD80 Sales 2015-2026 (K Pcs)
Figure 16. Global T Lymphocyte Activation Antigen CD80 Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global T Lymphocyte Activation Antigen CD80 Sales Market Share by Region (2015-2020)
Figure 18. Global T Lymphocyte Activation Antigen CD80 Sales Market Share by Region in 2019
Figure 19. Global T Lymphocyte Activation Antigen CD80 Revenue Market Share by Region (2015-2020)
Figure 20. Global T Lymphocyte Activation Antigen CD80 Revenue Market Share by Region in 2019
Figure 21. Global T Lymphocyte Activation Antigen CD80 Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by T Lymphocyte Activation Antigen CD80 Revenue in 2019
Figure 23. T Lymphocyte Activation Antigen CD80 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global T Lymphocyte Activation Antigen CD80 Sales Market Share by Type (2015-2020)
Figure 25. Global T Lymphocyte Activation Antigen CD80 Sales Market Share by Type in 2019
Figure 26. Global T Lymphocyte Activation Antigen CD80 Revenue Market Share by Type (2015-2020)
Figure 27. Global T Lymphocyte Activation Antigen CD80 Revenue Market Share by Type in 2019
Figure 28. Global T Lymphocyte Activation Antigen CD80 Market Share by Price Range (2015-2020)
Figure 29. Global T Lymphocyte Activation Antigen CD80 Sales Market Share by Application (2015-2020)
Figure 30. Global T Lymphocyte Activation Antigen CD80 Sales Market Share by Application in 2019
Figure 31. Global T Lymphocyte Activation Antigen CD80 Revenue Market Share by Application (2015-2020)
Figure 32. Global T Lymphocyte Activation Antigen CD80 Revenue Market Share by Application in 2019
Figure 33. North America T Lymphocyte Activation Antigen CD80 Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America T Lymphocyte Activation Antigen CD80 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America T Lymphocyte Activation Antigen CD80 Sales Market Share by Country in 2019
Figure 36. North America T Lymphocyte Activation Antigen CD80 Revenue Market Share by Country in 2019
Figure 37. U.S. T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America T Lymphocyte Activation Antigen CD80 Market Share by Type in 2019
Figure 42. North America T Lymphocyte Activation Antigen CD80 Market Share by Application in 2019
Figure 43. Europe T Lymphocyte Activation Antigen CD80 Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe T Lymphocyte Activation Antigen CD80 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe T Lymphocyte Activation Antigen CD80 Sales Market Share by Country in 2019
Figure 46. Europe T Lymphocyte Activation Antigen CD80 Revenue Market Share by Country in 2019
Figure 47. Germany T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe T Lymphocyte Activation Antigen CD80 Market Share by Type in 2019
Figure 58. Europe T Lymphocyte Activation Antigen CD80 Market Share by Application in 2019
Figure 59. Asia Pacific T Lymphocyte Activation Antigen CD80 Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific T Lymphocyte Activation Antigen CD80 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific T Lymphocyte Activation Antigen CD80 Sales Market Share by Region in 2019
Figure 62. Asia Pacific T Lymphocyte Activation Antigen CD80 Revenue Market Share by Region in 2019
Figure 63. China T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific T Lymphocyte Activation Antigen CD80 Market Share by Type in 2019
Figure 86. Asia Pacific T Lymphocyte Activation Antigen CD80 Market Share by Application in 2019
Figure 87. Latin America T Lymphocyte Activation Antigen CD80 Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America T Lymphocyte Activation Antigen CD80 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America T Lymphocyte Activation Antigen CD80 Sales Market Share by Country in 2019
Figure 90. Latin America T Lymphocyte Activation Antigen CD80 Revenue Market Share by Country in 2019
Figure 91. Mexico T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America T Lymphocyte Activation Antigen CD80 Market Share by Type in 2019
Figure 98. Latin America T Lymphocyte Activation Antigen CD80 Market Share by Application in 2019
Figure 99. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa T Lymphocyte Activation Antigen CD80 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Market Share by Country in 2019
Figure 102. Middle East and Africa T Lymphocyte Activation Antigen CD80 Revenue Market Share by Country in 2019
Figure 103. Turkey T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E T Lymphocyte Activation Antigen CD80 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E T Lymphocyte Activation Antigen CD80 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Share by Type in 2019
Figure 110. Middle East and Africa T Lymphocyte Activation Antigen CD80 Market Share by Application in 2019
Figure 111. North America T Lymphocyte Activation Antigen CD80 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America T Lymphocyte Activation Antigen CD80 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe T Lymphocyte Activation Antigen CD80 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe T Lymphocyte Activation Antigen CD80 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific T Lymphocyte Activation Antigen CD80 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific T Lymphocyte Activation Antigen CD80 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America T Lymphocyte Activation Antigen CD80 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America T Lymphocyte Activation Antigen CD80 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa T Lymphocyte Activation Antigen CD80 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa T Lymphocyte Activation Antigen CD80 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
Tリンパ球活性化抗原CD86の世界市場（～2026年） Market Analysis and Insights: Global T Lymphocyte Activation Antigen CD86 Market The global T Lymphocyte Activation Antigen CD86 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global T Lymphocyte Activation Antigen CD86 Scop…- 癌胎児性抗原（CEA）の世界市場（～2026年） Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period. Market Analysis and Insights: Global Carcinoembryonic Anti…
- 細胞傷害性T細胞タンパク質4の世界市場（～2026年） Market Analysis and Insights: Global Cytotoxic T Lymphocyte Protein 4 Market The global Cytotoxic T Lymphocyte Protein 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cytotoxic T Lymphocyte Protein 4 Scope and Market…
- 前立腺特異抗原の世界市場（～2026年） Market Analysis and Insights: Global Prostate Specific Antigen Market The global Prostate Specific Antigen market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Specific Antigen Scope and Market Size Prostate Specif…
- 白血球表面抗原CD47の世界市場（～2026年） Market Analysis and Insights: Global Leukocyte Surface Antigen CD47 Market The global Leukocyte Surface Antigen CD47 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Leukocyte Surface Antigen CD47 Scope and Market Size …